DM-1/500
Description
- Combination therapy for effective management of type 2 diabetes
- Glimepiride (1 mg): Enhances insulin secretion from pancreatic β-cells
- Metformin (500 mg): Reduces hepatic glucose production and improves insulin sensitivity
- Helps control both fasting and post-meal blood glucose levels
- May assist in mild weight loss or weight neutrality
- Generally well-tolerated and suitable for long-term use
- To be taken with meals to minimize gastrointestinal side effects
Composition
Glimepiride 1 mg + Metformin Hydrochloride 500 mg
Benefits
DM-1/500 provides comprehensive blood sugar control through a synergistic mechanism, targeting both insulin secretion and insulin resistance. It helps lower fasting and postprandial blood glucose levels effectively, reduces the risk of diabetes-related complications, and supports better metabolic balance. The combination may also help manage weight and improve lipid profiles when combined with lifestyle changes. DM-1/500 is particularly beneficial for adults with type 2 diabetes who require more than monotherapy to maintain optimal glycemic control.
Introduction
DM-1/500 is an oral antidiabetic medication that combines two widely used agents — Glimepiride and Metformin — for the effective management of type 2 diabetes mellitus. Glimepiride is a sulfonylurea that stimulates the pancreas to release more insulin, while Metformin, a biguanide, works by reducing glucose production in the liver and improving insulin sensitivity. This dual-action combination helps in achieving better glycemic control and minimizing blood sugar fluctuations, making DM-1/500 a trusted option for long-term diabetes care.
